Open Notebooks produced by PHIRI.eu.
PHIRI is the roll-out of the research infrastructure on population health information that aims to facilitate and generate the best available evidence for research on health and well-being of populations as impacted by COVID-19. PHIRI allows for better coordinated European efforts across national and European stakeholders to generate the best COVID-19 population health knowledge. In doing so, PHIRI is laying the foundation to build a Distributed Infrastructure on Population Health (DIPoH) to be used to overcome future crisis and ensure the sustainability of the project. The intent is to support research across Europe through the identification, access, assessment and reuse of population health and non-health data to underpin public health policy decisions. This is achieved through a close collaboration with 41 partners across 30 countries over a period of 36 months (November 2020 - November 2023). The project is divided in 9 ambitious work packages with three transversal topics. PHIRI builds on the achievements of the BRIDGE Health and the Joint Action on Health Information (InfAct) projects.
Research question: Has there been any increase in surgical and/or co-adjuvant (i.e. radiotherapy, chemotherapy, inmunotherapy) treatments delay in elegible women diagnosed of breast cancer, as a consequence of the COVID19 crisis?
Cohort description: Women, 18 years old or older, with a first diagnosis of breast cancer between 2017-01-01 until today.
More information on Zenodo:
